Dusty is an example of what neglected thyroid disease can do.
CANINE AUTOIMMUNE THYROID DISEASE
AND SYMPTOMS OF HYPOTHYROIDISM
CANINE AUTOIMMUNE THYROID DISEASE: COMMON PROBLEM OF PUREBRED DOGS
The
information provided here outlines an approach that has been used
successfully by the author to reduce the prevalence of clinically
expressed canine thyroid disease within susceptible families or breeds.
EARLY THYROID DISEASE (THYROIDITIS)
COMPENSATORY AND CLINICAL CANINE HYPOTHYROIDISM
Most
of the confusion about the diagnosis and treatment of thyroid disease
in purebred or mixed breed dogs today stems from the expectation that
affected animals must show clinical signs of inadequate thyroid
hormonal production (i.e. hypothyroidism) in order to have the disease.
The term hypothyroidism has been loosely applied to describe all stages
of this disease process whereas strictly speaking it should be reserved
for the end-stages when the animal's thyroid gland is no longer capable
of producing sufficient hormone(s) to sustain clinical health. At this
point, the dog can express any number of the non-specific multisystem
signs of thyroid dysfunction. But let's start at the beginning.
The
most common cause of canine thyroid disease is autoimmune thyroiditis
(estimated 90% of cases). Thyroiditis is an immune-mediated process
that develops in genetically susceptible individuals and is
characterized by the presence of antithyroid antibodies in the blood or
tissues. Thyroiditis is believed to start in most cases around puberty,
and gradually progress through mid-life and old age to become
clinically expressed hypothyroidism once thyroid glandular reserve has
been depleted. During this process, the animal or person becomes more
susceptible to immune-mediated or other diseases affecting various
target tissues and organs. The prerequisite genetic basis for
susceptibility to this disorder has been in established in humans, dogs
and several other species.
The above explanation helps us to
appreciate existing confusion and controversy within the veterinary
profession regarding whether or not testing or treatment is indicated
for dogs that fail to show typical signs of hypothyroidism. In fact, we
have only recently begun to recognize the subtle signs of early thyroid
dysfunction in dogs as prevalence of the autoimmune form of the
condition has increased within and among dog breeds. Today, some 50
breeds are genetically predisposed to develop thyroid disease.
GENETIC SCREENING FOR THYROID DISEASE
These
thyroid panels and antibody tests can also be used for genetic
screening of apparently healthy animals to evaluate their fitness for
breeding. A bitch with antithyroid antibodies in her blood may pass
these along to her puppies in her colostral milk. Also, any dog having
circulating antithyroid antibodies can eventually develop clinical
symptoms of thyroid or other autoimmune diseases. Therefore, thyroid
screening can be very important for potential breeding stock.
Thyroid
testing for genetic screening purposes is less likely to be meaningful
before puberty. Screening is initiated, therefore, once healthy dogs
and bitches have reached sexual maturity (between 10-14 months in males
and during the first anestrus period for females following their maiden
heat). Anestrus is a time when the female sexual cycle is quiescent,
thereby removing any influence of sex hormones on baseline thyroid
function. This period generally begins 12 weeks from the onset of the
previous heat and lasts one month or longer. The interpretation of
results from baseline thyroid profiles in intact females is more
reliable when they are tested in anestrus. Testing for health screening
is performed at 12-16 weeks from the onset of the previous heat. In
fact, genetic screening of intact females for other parameters like von
Willebrand's disease or wellness health and reproductive checkups
should also be scheduled in anestrus females. Once the initial thyroid
profile is obtained, dogs and bitches should be rechecked on an annual
basis to assess their own health. Annual results permit comparisons
that should reveal early evidence of developing thyroid disease or
dysfunction. This also allows for early treatment where indicated to
abort the development or advancement of clinical signs associated with
hypothyroidism.
Healthy young dogs (less than 15-18 months of
age) should have thyroid baseline levels for all parameters in the
upper 1/2 to 1/3 of the adult normal ranges. In fact, for optimum
thyroid function in screening breeding stock, levels should be at least
at the midpoint of the laboratory normal ranges, because lower levels
may well be indicative of the early stages of thyroiditis among
relatives of dog families known to have thyroid disease.
TREATMENT OF THYROID DISEASE
The
new information summarized here has changed our approach to treatment
and control of thyroid disease. In addition to providing thyroid
supplementation for dogs showing the typical signs of thyroid disease,
we now know that treatment of dogs showing the early stages of
thyroiditis (based on the testing described above) is necessary and
important to correct the underlying thyroid imbalance, reduce the risk
of developing other related immune-mediated disorders, and to control
or prevent the process of thyroiditis from progressing to depletion and
exhaustion of the thyroid gland.
1. Type of Treatment
The
treatment of choice because of its wide safety margin and efficacy is
T4 hormone (L - or levothyroxine). The most commonly used brand names
are Soloxine (Daniels) and Synthroid (Flint) and we recommend either of
these over generics especially for the smaller breeds. Use of T3
hormone (triiodothyronine) is not recommended for initial use because
toxicity can more easily develop with this product; T3 is the
intercellular hormone whereas most of T4 must be first converted to T3
before it achieves its metabolic effect. In some cases where the
animal's body cannot properly convert T4 to T3, the dog will need both
T4 and T3 therapy to correct the problem. For this purpose, the general
rule of thumb is to give from 2/3 to a full dose of T4 and a 1/3 dosage
of T3 (i.e., 0.1 mg per 10-20 pounds of T4 plus 1 ugm per pound of T3
twice daily). However, no dog should be treated with these thyroid
hormonal preparations without having proper veterinary testing, medical
examination and follow-up.
2. Frequency of Treatment
Thyroid
hormones should always be given twice daily to effect the best
response. Until recently, veterinarians have been advised to give
treatment to effect either once or twice daily because data on this
point was unclear. We now know that the half-life of T4 in the dog is
about 10-12 hours (much shorter than humans); for T3, it's only 6-8
hours. Thus, about half of the hormone is metabolized and excreted from
the body within 12 hours. Furthermore, twice daily dosing aids in
controlling thyroiditis because it shuts off pituitary production of
TSH by negative feedback in concert with the half-life of the hormone.
In other words, the dog's own thyroid follicular cells become quiescent
and are less likely to stimulate production of the antithyroid
antibodies responsible for the disease. (Obviously these are simplistic
explanations of the complex metabolic, immunologic and biochemical
events involved.) Contrary to some popular wisdom, treatment with
thyroid hormone does not destroy or suppress the potential of the gland
to respond on its own once treatment is stopped for whatever reason.
The latest veterinary research shows that it takes the thyroid gland up
to 30 days to recover its full potential once therapy is withdrawn.
Therefore if an animal has been medicated, where the diagnosis is
unclear, treatment should be withdrawn (if it's clinically safe to do
so) for 30 days before the animal is retested with the complete type
thyroid profile described above.
Follow-up testing after
initiating treatment is usually performed after four to eight weeks of
therapy. The sample should be taken 4-6 hours after the morning dosage
and optimum results will show thyroid values in the upper third of
normal ranges at the peak time of absorption. Dosage can then be
adjusted accordingly if needed. Dogs on long term therapy with thyroid
hormones should be monitored with complete panels (not just T4 as you
need to be sure the dog's body is converting the T4 medication properly
to T3) on a regular basis (every 6-12 months).
CLINICAL SIGNS OF CANINE HYPOTHYROIDISM
Alterations in Cellular Metabolism
weakness
/ stiffness / laryngeal paralysis / facial paralysis / tragic
expression / knuckling or dragging feet / muscle wasting /
megaesophagus / head tilt / drooping eyelids
Neuromuscular Problems
seizures
/ mental dullness / exercise intolerance / neurologic signs
polyneuropathy / lethargy / weight gain / cold intolerance / mood
swings hyperexcitability / stunted growth / chronic infections
Dermatologic Diseases
dry,
scaly skin and dandruff / coarse, dull coat / bilateral symmetrical
hair loss / rat tail, puppy coat / hyperpigmentation / seborrhea or
greasy skin pyoderma or skin infections / myxedema / chronic offensive
skin odor
Reproductive Disorders
infertility of either sex /
lack of libido / testicular atrophy / hypospermia aspermia / prolonged
interestrus interval / absence of heat cycles / silent heats /
pseudopregnancy / weak, dying or stillborn pups
Cardiac Abnormalities
slow heart rate (bradycardia) / cardiac arrhythmias / cardiomyopathys
Gastrointestinal Disorders
constipation / diarrhea / vomiting
Hematological Disorders
bleeding / bone marrow failure / low red blood cells / low white blood cells / low platelets
Ocular Diseases
corneal
lipid deposits / corneal ulceration / uveitis Keratococonjunctivitis /
sicca or dry eye / infections of eyelid glands (Meibomian gland)
Other Associated Disorders
lgA
deficiency / loss of smell (dysosmia) / loss of taste / glycosuria /
chronic active hepatitis / other endocrinopathies adrenal, pancreatic,
parathyroid
Related Articles on Thyroid Disease
-BEHAVIORAL CHANGES ASSOCIATED WITH THYROID DYSFUNCTION IN DOGS
-THYROID CAN ALTER BEHAVIOR
-CANINE THYROID DISEASE